Publication | Closed Access

Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models

Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyImmune Checkpoint InhibitorImmunocompetent Mouse ModelsImmunotherapyCd40l Enhances ImmunotherapyRadiation OncologyTumor MicroenvironmentTumor Biology